Article
Pharmaco-nutritional strategies to increase nitric oxide signaling in Raynaud phenomenon (Nivose): a series of N-of-1 trials
2026-08-14
Abstract excerpt
<h4>Background: </h4> Treatment of Raynaud phenomenon(RP) with oral vasodilators(calcium channel block-ers and phosphodiesterase type 5 inhibitors) has shown moderate efficacy, may not benefit to all patients, and adverse effects often compromise long-term treatment. In addition, a large placebo effect may jeopardize the assessment of treatment benefits. Pharmaconutritional strategies aiming at increasing nitric o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5c774466-ade3-5ab4-8828-52b1afd508fe
- DOI
- 10.64898/2026.08.13.26360355
